Department of Laboratory Medicine, Zhongshan City People's Hospital, 528403 Zhongshan, Guangdong, China.
School of Pharmaceutical Sciences, Sun Yat-Sen University, 510006 Guangzhou, Guangdong, China.
ACS Appl Mater Interfaces. 2024 Jun 12;16(23):29760-29769. doi: 10.1021/acsami.4c03382. Epub 2024 May 30.
Multivalent receptor-ligand interactions (RLIs) exhibit excellent affinity for binding when targeting cell membrane receptors with low expression. However, existing strategies only allow for limited control of the valency and spacing of ligands for a certain receptor, lacking recognition patterns for multiple interested receptors with complex spatial distributions. Here, we developed flexible DNA nanoclaws with multivalent aptamers to achieve powerful cell recognition by controlling the spacing of aptamers to match the spatial patterns of receptors. The DNA nanoclaw with spacing-controllable binding sites was constructed via hybrid chain reaction (HCR), enabling dual targeting of HER2 and EpCAM molecules. The results demonstrate that the binding affinity of multivalent DNA nanoclaws to tumor cells is enhanced. We speculate that the flexible structure may conform better to irregularly shaped membrane surfaces, increasing the probability of intermolecular contact. The capture efficiency of circulating tumor cells successfully verified the high affinity and selectivity of this spatial pattern. This strategy will further promote the potential application of DNA frameworks in future disease diagnosis and treatment.
多价受体-配体相互作用(RLIs)在靶向表达水平较低的细胞膜受体时,表现出优异的结合亲和力。然而,现有的策略仅允许对特定受体的配体的价态和间距进行有限的控制,缺乏对具有复杂空间分布的多个感兴趣受体的识别模式。在这里,我们开发了具有多价适体的灵活 DNA 纳米爪,通过控制适体的间距来匹配受体的空间模式,从而实现强大的细胞识别。通过杂交链反应(HCR)构建了具有间距可控结合位点的 DNA 纳米爪,实现了对 HER2 和 EpCAM 分子的双重靶向。结果表明,多价 DNA 纳米爪与肿瘤细胞的结合亲和力增强。我们推测,这种灵活的结构可能更好地符合不规则形状的膜表面,增加分子间接触的概率。循环肿瘤细胞的捕获效率成功验证了这种空间模式的高亲和力和选择性。该策略将进一步推动 DNA 框架在未来疾病诊断和治疗中的潜在应用。